Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO

Published:2019-04 Issue:4 Volume:143 Page:1629-1633.e2
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Hanania Nicola A.,Chipps Bradley E.,Griffin Noelle M.,Yoo Bongin,Iqbal Ahmar,Casale Thomas B.

Funder

Novartis

Novartis Pharmaceuticals Corporation

Genentech

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization;Vaz Fragoso;Int J Chron Obstruct Pulmon Dis,2017

2. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report;Woodruff;Am J Respir Crit Care Med,2017

3. Disease burden of patients with asthma/COPD overlap in a US claims database: impact of ICD-9 coding-based definitions;Wurst;COPD,2017

4. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial;Wenzel;Lancet,2016

5. Omalizumab treatment in asthma-COPD overlap syndrome;Tat;J Asthma,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma COPD Overlap;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

2. The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study;European Journal of Medical Research;2024-02-04

3. A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study;World Allergy Organization Journal;2023-12

4. GEMA 5.3. Spanish Guideline on the Management of Asthma;Open Respiratory Archives;2023-10

5. Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab;Clinical & Experimental Allergy;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3